Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00585247
Other study ID # 20064815
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2006
Est. completion date August 2012

Study information

Verified date October 2022
Source University of California, Irvine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Port wine stains are red birthmarks that without treatment persist for a lifetime. They are frequently found on the face and can be conspicuous and disfiguring, negatively impacting social interactions for these patients. Treating Port wine stains is difficult. The standard of care is to use laser treatment, but over 80% of patients fail to completely clear despite multiple treatments. The growth of additional blood vessels (angiogenesis) following the Laser treatment is likely an important factor in why these lesions persist despite therapy.


Description:

Imiquimod is a topical cream that affects the immune response and has been noted to inhibit blood vessel formation. It has been used to successfully treat other vascular growths such as hemangiomas. The research can use imiquimod cream 5% cream apply to port wine stains after laser therapy to improve lightening of port wine stains. The imiquimod 5% cream cream apply to Port wine stains everyday for 8 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date August 2012
Est. primary completion date August 2012
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Diagnosis of Port Wine Stain birthmark - Male and female subjects of any age who are in good health. - Fitzpatrick skin type I-VI Exclusion Criteria: - Pregnant or lactating - History of cutaneous photosensitivity - History of hypersensitivity to imiquimod 5% cream or any of its components - History of photodermatoses

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Imiquimod
Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks
Other:
Placebo
Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks

Locations

Country Name City State
United States Beckman Laser Institute Medical and Surgical Cilnic Irvine California

Sponsors (2)

Lead Sponsor Collaborator
University of California, Irvine Beckman Laser Institute University of California Irvine

Country where clinical trial is conducted

United States, 

References & Publications (1)

Tremaine AM, Armstrong J, Huang YC, Elkeeb L, Ortiz A, Harris R, Choi B, Kelly KM. Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod. J Am Acad Dermatol. 2012 Apr;66(4):634-41. doi: 10.1016/j. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change From Baseline in a* and E at 8 Weeks Change in a* and ?E is a way to quantify PWS treatment outcome: a* is the erythema of the vascular lesions and varies from +60 for green to -60 for red with a value of +9.28 for Normal Skin. Higher a* values indicates a greater reduction in erythema hence better treatment outcome. ?E detects all three dimensions of colorspace (L*a*b*) and represents the difference in color between normal and PWS skin. Range of ?E is 0 to 100. Higher values indicates improved treatment efficacy by greater skin color improvement. 8 weeks baseline
See also
  Status Clinical Trial Phase
Withdrawn NCT01438047 - Optical Frequency Domain Imaging (OFDI) in Dermatology N/A
Terminated NCT00782483 - Personalized Interactive Laser Therapy of Port Wine Stain N/A
Completed NCT03948997 - The Role of Angiogenesis-related Pathways in the Development of Port Wine Stains N/A
Completed NCT01364857 - French National Cohort of Children With Port Wine Stain N/A
Withdrawn NCT00969397 - Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks Phase 1/Phase 2
Completed NCT00800722 - A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks. Phase 1
Active, not recruiting NCT00247299 - Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform N/A
Completed NCT00580736 - Optical Clearing of the Skin in Conjunction With Laser Treatments Phase 1
Completed NCT00540566 - Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Withdrawn NCT02035319 - Effect of Laser Treatment on Capillary Malformations N/A
Withdrawn NCT01166919 - Pilot Study on the Use of the Matrix Radiofrequencyfor Treatment of Port Wine Stain Birthmarks Phase 1
Completed NCT00830466 - A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks. Phase 1
Completed NCT00540371 - Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences
Completed NCT01333553 - Monitoring the Response of Port Wine Stain Birthmarks to Laser Therapy With Wide-field Functional Imaging Technologies
Withdrawn NCT00580944 - Combined Alexandrite and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks Phase 1